Investigation Overview
March 21, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Juno Therapeutics Inc (NASDAQ:JUNO) was announced over potential breaches of fiduciary duties by certain officers and directors at Juno Therapeutics. The investigation by a law firm concerns whether certain Juno Therapeutics Inc directors breached their fiduciary duties. ...
You must register (for free) or login to view the entire investigation.